References

Abe K, Misawa M (2003) Astrocyte stellation induced by Rho kinase inhibitors in culture.

Brain Res Dev Brain Res 143:99-104 Arai M, Sasaki Y, Nozawa R (1993) Inhibition by the protein kinase inhibitor HA1077 on the activation of NADPH oxidase in human neutrophils. Biochem Pharmacol

46:1487-1490

Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, Hidaka H (1987) Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 241:1033-1040

Bito H, Furuyashiki T, Ishihara H, Shibasaki Y, Ohashi K, Mizuno K, Maekawa M, Ishizaki T, Narumiya S (2000) A critical role for a Rho-associated kinase, p160R0CK, in determining axon outgrowth in mammalian CNS neurons. Neuron 26:431-441 Chiba Y, Takada Y, Miyamoto S, Mitsui-Saito M, Karaki H, Misawa M (1999) Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperactive rats. Br J Pharmacol 127:597-600 Engh RA, Girod A, Kinzel V, Huber R, Bossmeyer D (1996) Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8 and H89. J Biol Chem 271:26157-26164 Fukui R, Amakawa M, Hoshiga M, Shibata N, Kohbayashi E, Seto M, Sasaki Y, Ueno T, Negoro N, Nakakoji T, II M, Nishiguchi F, Ishihara T, Ohsawa N (2000) Increased migration in late G1 phase in cultured smooth muscle cells. Am J Physiol Cell Physiol 279:C999-C1007

Grubb RL Jr, Raichle ME, Eichling JO, Gado MH (1977) Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans. J Neu-rosurg 46:446-453

Hagiwara M, Inagaki M, Hidaka H (1987) Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase. Mol Pharmacol 31:523-528 Hidaka H, Tanaka T (1983) Naphthalenesulfonamides as calmodulin antagonists. Methods Enzymol 102:185-194 Hidaka H, Yamaki T, Asano M, Totsuka T (1978a) Involvement of calcium in cyclic nucle-

otide metabolism in human smooth muscle. Blood Vessels 15:55-64 Hidaka H, Asano M, Iwadare S, Matsumoto I, Totsuka T, Aoki N (1978b) A novel vascular relaxing agent, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide which affects vascular smooth muscle actomyosin. J Pharmacol Exp Ther 207:8-15 Hidaka H, Yamaki T, Totsuka T, Asano M (1979) Selective inhibitors of Ca2+-binding modulator of phosphodiesterase produce vascular relaxation and inhibit actin-myo-sin interaction. Mol Pharmacol 15:49-59 Hidaka H, Inagaki M, Kawamoto S, Sasaki Y (1984) Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041 Hidaka H, Watanabe M, Kobayashi R (1991) Properties and use of H-series compounds as protein kinase inhibitors. Methods Enzymol 201:328-339 Ikenoya M, Hidaka H, Hosoya T, Suzuki M, Yamamoto N, Sasaki Y (2002) Inhibition of rho-kinase induced myristoylated alanine-rich C kinase substrate (MARCKS) phos-phorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor. J Neurochem 81:9-16 Inagaki M, Watanabe M, Hidaka H (1985) N-(2-aminoethyl)-5- isoquinolinesulfonamide, a newly synthesized protein kinase inhibitor, functions as a ligand affinity chroma-tography. J Biol Chem 260:2922-2925 Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, Nagumo H, Seto M, Sasaki Y, Takuwa Y (2003) Essential role of rho kinase in the Ca2+ sensitization of prostaglandin F(2alpha)-induced contraction of rabbit aortae. J Physiol 546:823-836 Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K (1994) Combined effect of L-arginie and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg 80:476-483

Kaneko T, Amano M, Maeda A, Goto H, Takahashi K, Ito M, Kaibuchi K (2000) Identification of calponin as a novel substrate of Rho-kinase. Biochem Biophys Res Commun 273:110-116

Katsumata N, Shimokawa H, Seto M, Kozai T, Yamawaki T, Kuwata K, Egashira K, Ikegaki I, Asano T, Sasaki Y, Takeshita A (1997) Enhanced myosin light chain phosphoryla-tions as a central mechanism for coronary artery spasm in a swine model with inter-leukin-1 beta. Circulation 96:4357-4363 Kimura K, Ito M, Amano M, Chihara K, Fukuta Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273:245-248 Kozma R, Sarner S, Ahmed S, Lim L (1997) Rho family GTPases and neuronal growth cone remodelling. Relationship between increased complexity induced Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol Cell Biol 17:1201-1211 Moolenaar WH, Kranenburg O, Postma FR, Zondag GC (1997) Lysophosphatidic acid:

G-protein signalling and cellular responses. Curr Opin Cell Biol 9:168-173 Nagumo H, Seto M, Sakurada K, Walsh MP, Sasaki Y (1998) HA1077, a protein kinase inhibitor, inhibits calponin phosphorylation on Ser175 in porcine coronary artery. Eur J Pharmacol 360:257-264 Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y (2000) Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 278:C57-65 Nagumo H, Ikenoya M, Sakurada K, Furuya K, Ikuhara, T, Hiraoka H, Sasaki Y (2001) Rho-associated kinase phosphorylates MARCKS in human neuronal cells. Biochem Biophys Res Commun 280:605-609 Ohno, S, Kawasaki H, Imajoh S, Suzuki K, Inagaki M, Yokokura H, Sakoh T, Hidaka H (1987) Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 325:161-166

Saito M, Ishikawa T, Matsushima S, Naka M, Hidaka H (1987) Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J Biol Chem 262:77967801

Sako K, Tsuchiya M, Yonemasu Y, Asano T (1991) HA1077, a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats. Eur J Pharmacol 209:39-43 Satoh S, Ikegaki I, Suzuki Y, Asano T, Shibuya M, Hidaka H (1996) Neuroprotective properties of a protein kinase inhibitor against ischemia-induced neuronal damage in rats and gerbils. Br J Pharmacol 118:1592-1598 Satoh S, Yamamoto Y, Toshima Y, Ikegaki I, Asano T, Suzuki Y, Shibuya M (1999a) Fa-sudil, a protein kinase inhibitor, prevents the development of endothelial injury and neutrophil infiltration in a two-haemorrhage canine subarachnoid model. J Clin Neu-rosci 6:394-399

Satoh S, Kobayashi T, Hitomi A, Ikegaki I, Suzuki Y, Shibuya M, Yoshida J, Asano T (1999b) Inhibition of neutrophil migration by a protein kinase inhibitor for the treatment of ischemic brain infarction. Jpn J Pharmacol 80:41-48 Seto M, Sasaki Y, Hidaka H, Sasaki Y (1991) Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle. Eur J Pharmacol 195:267272

Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Okamoto S, Kikuchi H, Takemae T, Hidaka H (1990) Dose escalation trial of a novel calcium antagonist

AT877, in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 107:11-15

Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M (1992) Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 76:571-577 Suzuki Y, Satoh S, Kimura M, Oyama H, Asano T, Shibuya M, Sugita K (1992) Effects of vasopressin and oxytocin on canine cerebral circulation in vivo. J Neurosurg 77:424431

Tachibana E, Harada T, Shibuya M, Saito K, Takayasu M, Suzuki Y, Yoshida J (1999) In-tra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) 141:13-19 Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, Kageyama N, Hidaka H (1986) The effects of HA compound calcium antagonists on delayed cerebral vaso-spasm in dogs. J Neurosurg 65:80-85 Tanaka T, Hidaka H (1980a) Hydrophobic regions function in calmodulin-enzymes interactions. J Biol Chem 255:11078-11080 Tanaka T, Naka M, Hidaka H (1980b) Activation of myosin light chain kinase by trypsin.

Biochem Biophys Res Commun 92:313-318 Trifaro JM, Lejen T, Rose SD, Pene TD, Barkar ND, Seward EP (2002) Pathways that control cortical F-actin dynamics during secretion. Neurochem Res 27:1371-1385 Tsuchiya M, Sako K, Yonemasu Y, Asano T (1993) The effects of HA1077, a novel protein kinase inhibitor, on reductions of cerebral blood flow and glucose metabolism following acute and/or chronic bilateral carotid artery ligation in Wistar rats. Exp Brain Res 97:233-238

Varsos VG, Liszczak TM, Han DH, Kistler JP, Vielma J, Black PM, Heros RC, Zervas NT (1983) Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model. J Neurosurg 58:11-17 Yamakami I, Isobe K, Yamaura A, Nakamura T, Makino H (1983) Vasospasm and regional cerebral blood flow (rCBF) in patients with ruptured intracranial aneurysms: Serial rCBF studies with the Xenon-133 inhalation method. Neurosurgery 13:394-401 Yamamoto Y, Ikegaki I, Sasaki Y, Uchida T (2000) The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit. J Cardiovasc Pharmacol 35:203-211

HEP (2005) 167:433-450 © Springer-Verlag 2005

0 0

Post a comment